Total Funding
86
57
Total FundingSeries B raised
Growth Score 86 in past quarter
-3 pts
Heat Score 57 in past quarter
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
120197
KS Bitusen is a drug research and development company specialising in muscle diseases and is a global Innovation R and D Leader.
- Seunghyo Jeong: Co-Founder & Co-Chief Executive Officer
- Jung Seung-hyo: Co-CEO
About the Company
KS Bitusen is a global Innovation R and D Leader in Sarcopenia Treatment Development. The company's therapeutics provide senile sarcopenia treatment that helps to fight against diseases, enabling healthcare companies to provide patients with treatment services.